Hepatitis Delta in Focus: Episode 4 of Answering the Questions on Screening, Diagnosis, and Treatment
In this podcast episode, listen to expert faculty perspectives on HDV management, including screening, staging liver disease, approach to treatment—such as whom to treat and for how long—and considerations for combination therapy.
Decera Clinical Education Infectious Disease Podcast · Tarik Asselah MD PhD, Ira Jacobson MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Tarik Asselah, MD, PhD, and Ira Jacobson, MD, provide expert insight on HDV screening, diagnosis, and management, including:
- Approach to screening
- Barriers to screening (eg, test availability)
- Disease progression and complications
- Differentiating between coinfection and superinfection
- Approach to treatment (eg, whom to treat and when, treatment options, considerations for combination therapy)
- Management of patients with decompensated cirrhosis
- Surrogate markers to measure treatment success
- Role of correcting thrombocytopenia before initiating therapy
Faculty:
Tarik Asselah, MD, PhD
Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France
Ira Jacobson, MD
Professor of Medicine
NYU School of Medicine
Director of Hepatology
Division of Gastroenterology and Hepatology
NYU Langone Health
New York, New York
Link to full program: https://bit.ly/3yp1Lxf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.